How size and genetic diversity shape lifespan across breeds of purebred dogs.
Level 5 - mechanism / opinion, no new human data
Animal demographic study analyzing canine database records without human data.
PubMed 36066765 · doi:10.1007/s11357-022-00653-w
What was done
The authors analyzed owner-reported lifespan and cause-of-death data from a large public database covering more than 40,000 purebred dogs across 118 breeds. To address right-censoring bias caused by disproportionate sampling of early-dying dogs in growing populations, they restricted analyses to completed birth cohorts. They evaluated the association of body size and genetic diversity (heterozygosity) with overall breed lifespan as well as two specific mortality categories: old age and cancer.
What was found
After adjusting for right-censoring, both smaller body size and higher genetic diversity were significantly associated with increased mean lifespan across breeds. Old-age lifespan and the proportion of deaths attributed to old age decreased with increasing body size and increased with greater genetic diversity. For cancer, larger body size was significantly associated with reduced lifespan and an increased proportion of cancer mortality; however, higher genetic diversity did not show a statistically significant reduction in proportional cancer mortality. Specific numerical effect sizes, confidence intervals, and p-values were not reported in the abstract.
Why it matters
The study provides evidence that inbreeding and low genetic diversity depress lifespan across dog breeds independently of body size, lending empirical support to outcrossing programs intended to improve purebred canine longevity and health.
Limits
The dataset relies on owner-reported lifespans and causes of death rather than standardized veterinary necropsies, introducing potential reporting and misclassification bias. Specific numerical estimates and effect sizes are omitted from the abstract, and the findings reflect breed-level averages in domestic dogs that cannot be directly translated to human clinical outcomes.